Conversely, in vitro research reported increased or unchanged levels in NASH patients’ livers and found that lysophosphocholin activates apoptosis by activating the tumor necrosis factor-α pathway [57,58]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.